Stock Events

Stock Events

Relmada Therapeutics (RLMD) Q3 2024 Earnings

7AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.91

-0.8

-0.7

-0.59

Details

Expected EPS

-0.8275

Actual EPS

-0.59

Surprise EPS

0.24

Surprise Percent

+28.7%

Description

Relmada Therapeutics (RLMD) has reported earnings of -0.59 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.